NCT05832489View on ClinicalTrials.gov

EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders

PHASE3RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 26, 2024

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Adult ADHDAdult-onset ADHD With Mood Disorder
Interventions
DRUG

Placebo

"Patients will have 2 imaging sessions (MRI and EEG) after either:~* methylphenidate immediate release 25 mg~* placebo~in a cross-over design. The two imaging sessions will be separated by 11 to 87 days."

DRUG

Methylphenidate immediate release 25mg

"Patients will have 2 imaging sessions (MRI and EEG) after either:~* methylphenidate immediate release 25 mg~* placebo~in a cross-over design. The two imaging sessions will be separated by 11 to 87 days."

Trial Locations (1)

67091

RECRUITING

Service de Psychiatrie 2, Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER